Objective: Patients with type 2 diabetes mellitus have an increased risk of fracture despite normal or increased bone mineral density (BMD). Studies on the relationship of glucose homeostasis with BMD phenotypes have been inconclusive because distinguishing the roles of insulin resistance and hyperglycaemia in bone remodelling is challenging. In this study, we sought to define the relationship of site-specific BMD with glucose homeostasis traits and anthropometric traits. Results: Two-hour glucose was negatively associated with arm BMD in women, which remained significant in multivariate analysis (β = −.15, P = .0015). Positive correlations between fasting insulin and BMD at weight-bearing sites, including pelvis (β = .22, P < .0001) and legs (β = .17, P = .001) in women and pelvis (β = .33, P < .0001) in men, lost significance after multivariate adjustment. Lean mass exhibited strong independent positive associations with BMD at multiple sites in both sexes.
| INTRODUC TI ON
Osteoporosis and type 2 diabetes (T2DM) are among the most common complex diseases in ageing societies. Diabetes not only causes vascular complications but also is strongly associated with musculoskeletal complications. Several large epidemiologic studies have observed significantly increased risk of fracture in patients with diabetes.
1 The Women's Health Initiative Observational Cohort study noted postmenopausal women with T2DM had a 20% increased risk of any fracture during 7 years of follow-up. 2 A meta-analysis including almost 840,000 men and women also found that patients with T2DM had a 70% increased risk of hip fracture.
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Despite the increased fracture risk, patients with T2DM have normal or even higher bone mineral density (BMD) at vertebral and femoral bones. 2 This counterintuitive phenomenon complicates assessment of skeletal health in patients with T2DM in current practice, which is heavily dependent on hip or vertebral BMD. This discrepancy raises the possibility that impairment in bone quality
and not bone quantity increases the risk of fracture in T2DM.
Various factors may contribute to the pathophysiology of skeletal impairment in T2DM. Advanced glycation end-products (AGEs),
by-products of unregulated glycation in the setting of hyperglycaemia, were shown to disrupt cross-linking of collagen in bone. 4 Oral hypoglycaemic agents such as thiazolidinediones 5 and sodiumglucose cotransporter 2 inhibitors 6 have also been directly or indirectly associated with reduced BMD and increased risk of fracture.
Deleterious effects of hyperglycaemia as well as glucose-lowering agents suggest a complex relationship between glucose and bone. In addition, patients with T2DM have been found to have a low bone turnover rate and increased sclerostin levels, suggesting suppressed Wnt signalling pathways, and therefore suppressed bone formation. 7 The effects of insulin resistance and hyperglycaemia, hallmarks of T2DM, on bone are not clearly understood, and the studies that examined the relationships among glucose homeostasis and BMD reported an inverse relationship between femoral and whole-body BMD and insulin sensitivity measured using intravenous glucose tolerance testing in 55 nondiabetic patients with ischaemic heart disease. Lastly, a study from Hungary performed euglycaemichyperinsulinaemic clamps in 20 healthy and 51 glucose intolerant female subjects and reported a negative relationship of total body glucose utilization with lumbar and femoral BMD in the healthy group but not in subjects with impaired glucose tolerance.
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Challenges to interpreting this literature arise from heterogenous cohorts with secondary factors affecting skeletal health, small numbers of subjects and use of diverse measurements such as fasting glucose, fasting insulin, HOMA-IR or calculated insulin sensitivity, which are not the best assessments of glucose homeostasis.
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The primary aim of our study was to clearly define the relationship of site-specific BMD with anthropometric traits and glucose homeostasis traits measured by both euglycaemic-hyperinsulinaemic clamps and a multitimepoint oral glucose tolerance test.
| MATERIAL S AND ME THODS

| Subjects
Metabolic and BMD phenotypes were assessed in the MexicanAmerican Coronary Artery Disease (MACAD) cohort, a study of Mexican-American families from Los Angeles. 16 To be classified as
Mexican and qualify for the study, subjects had to report at least 
| Phenotyping
Subjects underwent a 3-day phenotyping protocol. On 1 day, fasting blood was obtained, followed by a 75-g oral glucose tolerance test (OGTT). On a separate day, a dual X-ray absorptiometry (DXA) scan was performed, and on a further day, a euglycaemichyperinsulinaemic clamp was performed.
The primary goal of the DXA scan was to assess body fat distribution (fat mass and lean mass). The regions of interest (ROIs) of these whole-body scans were those frequently used for body composition assessment, yet also provide accurate information on BMD. 17 In this study, we focused on arm ROIs that included the en- We examined anthropometric indices including BMI and waistto-hip ratio (WHR) and total lean mass and total fat mass derived from the DXA scans.
| Statistical analysis
Log-transformed (BMI, IGI30, fasting insulin and 2-hour glucose values) or square-root transformed (total fat mass, M value and MCRI) trait values were used to normalize the distribution for statistical analysis. Categorical traits (sex, diabetes and current smoking status)
were coded as 0 and 1 prior to inclusion in analyses. t tests for quantitative traits and chi-square tests for categorical traits were used to compare traits between men and women.
All of the following regression analyses were performed separately for male and female subjects, considering the significant gender differences in body composition and skeletal size. 22 Generalized estimating equations (GEE) were used to assess the effects of single traits (univariate analyses) or joint effects of multiple traits (multivariate analyses) on BMD, adjusting for familial relationships. The weighted GEE1 23 was computed assuming an exchangeable correlation structure and using the sandwich estimator of the variance to account for familial correlation present in family data. GEE was used to derive standardized regression coefficients, which in any one regression equation are measured on the same scale, with a mean of zero and a standard deviation of one. They are then directly comparable to one another, with the largest coefficient indicating which independent variable has the greatest association with the dependent variable.
Using GEE to adjust for familial relationships, we computed univariate correlation coefficients between each regional BMD (pelvis, lumbar spine (LS), arm and leg) and glucose homeostasis indices and body composition variables. At each BMD site, the variables with statistical significance in univariate analyses were selected for subsequent multivariate analysis. Multiple regression analyses were performed to identify the variables independently associated with each regional BMD. Given that 13 variables were tested in the univariate analyses, only variables meeting a multiple testing corrected P value cut-off of .004 (0.05/13) were advanced to multivariate analyses. In the multivariate analyses, P values of <.05 were considered significant. TA B L E 2 Association of site-specific bone mineral density (BMD) with anthropometric and glucose homeostasis traits To assess for multicollinearity within the regression models, variance inflation factors (VIF) were calculated. VIF less than 5 are acceptable while VIF above 10 indicate poorly estimated regression coefficients due to multicollinearity.
TA B L E 1 Clinical characteristics
| RE SULTS
The clinical characteristics of the 787 subjects are shown in Table 1 .
Subjects were young, with median age of 34 years, and 57% were women. Body composition was significantly different in men and women, with women having higher fat mass. Men had significantly higher lean mass and bone density at the pelvis, arms and legs. The metabolic profiles were also different by sex. Men tended to have higher insulin sensitivity (M value); however, insulinogenic index (IGI30) was significantly higher in women. Previously unknown diabetes was revealed by oral glucose tolerance testing in 5.0% of men and 5.4% of women. Given that they had mild diabetes and were not taking antidiabetic agents when phenotyped, these subjects were included in the analyses herein.
Univariate analyses demonstrated positive correlations between fasting insulin and BMD at the pelvis and legs in women, and at the pelvis in men (Table 2 ). In women, insulinogenic index (IGI30) was also positively associated with pelvis and leg BMD. There was no significant correlation of IGI30 or MCRI with BMD at any site in men.
Insulin sensitivity (M value), however, was negatively correlated with BMD at the pelvis in men. In addition, 2-hour glucose was inversely associated with arm BMD in women. Male subjects did not show any significant relationship between 2-hour glucose and BMD. In terms of body composition, total lean mass was positively correlated with BMD at all sites in both sexes, only missing statistical significance at LS in men. Total fat mass also showed positive association but only at weight-bearing sites such as pelvis and legs in women and pelvis in men.
Bone mineral density traits that were correlated with more than one glucose homeostasis or anthropometric trait were subjected to multivariate analyses. In multivariate analyses, the positive association of fasting insulin and BMD at weight-bearing sites disappeared after adjustment for body composition and other significant glucose homeostasis indices (Tables 3 and 4 correlation with BMD at all sites, but total fat mass was not significant after adjustment for total lean mass.
All of the above analyses were repeated with exclusion of the subjects with diabetes, which yielded essentially the same results (data not shown).
| D ISCUSS I ON
Our study included the largest number of subjects with euglycaemichyperinsulinaemic clamps used to examine the relationship between glucose homeostasis and bone mineral density at different sites.
From these data, the direction of causality between bone and glucose homeostasis remains to be determined.
Recent studies have suggested bone is an endocrine organ that plays a role in metabolism as osteocytes release undercarboxylated osteocalcin, which enhances insulin secretion from beta-cells and increases insulin sensitivity. 24 In the so-called "bone-pancreas For each bone mineral density (BMD) site, results for all independent variables included in the multiple regression model are displayed. Variance inflation factors were 1.00 for both variables for arm; ranged from 1.07-5.43 for leg; and 1.07-5.43 for pelvis.
TA B L E 3 Multivariate analyses in women
loop," insulin works as an anabolic hormone on bone remodelling, stimulating osteoblast differentiation and proliferation as well as osteoclastogenesis through receptor activator of nuclear factor kappa-B ligand expression to maintain bone turnover. 25 However, the anabolic effect of insulin does not seem to be absolutely required in bone remodelling, given the observation of normal bone density in bone-specific insulin receptor (IR) knock-out mice, which may be explained by increased insulin-like growth factor-1 signalling.
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In our study, we observed positive correlation between fasting insulin and BMD in both sexes. Interestingly, the positive association was only noted at the weight-bearing sites such as pelvis and legs in women and pelvis in men. This positive association from univariate analysis, however, disappeared after the adjustment for other significant variables including body composition, and only lean mass remained significant in multivariate analysis. We can postulate that insulin might exert anabolic effects on bone remodelling but through mechanical stimuli generated by lean mass. Furthermore, insulin might sensitize the response to mechanical loading in bone, which needs to be further studied.
In addition, we found a significant negative association between 2-hour glucose and arm BMD in univariate analysis. This association was only noted in women and persisted after adjusting for other glucose homeostasis indices and body composition in multivariate analysis. Without any significant association with insulin sensitivity (M value), a direct harmful effect of increasing glucose levels on bone mass can be postulated.
Two mechanisms whereby chronic hyperglycaemia leads to microvascular complications are the polyol pathway (aldose reductase converts glucose to sorbitol, which damages tissues) and accumulation of advanced glycation end-products (AGEs). Studies have implicated both of these as having adverse effects on bone.
Galactose-fed rats exhibited suppressed osteocalcin and bone loss, which was prevented by treating with an aldose reductase inhibitor, suggesting the polyol pathway plays a negative role in bone metabolism. 27 In a diabetic mouse model with induced periodontitis, blockade of receptors for AGEs decreased alveolar bone loss and inflammatory markers including tissue-destructive matrix metalloproteinases.
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The sex-specific and site-specific associations in our study are not fully understood. Sex hormones play a critical role in bone remodelling, contributing significantly to sexual dimorphism in bone phenotypes as they interact with the growth hormone axis and mechanical stimuli. 29 In addition, oestrogen enhances glucose uptake and modulates glucose metabolism in muscle and fat. 30 We can speculate that sex hormones also affect glucose metabolism in bone;
oestrogen may facilitate glucose uptake in bone tissue, augmenting the negative effect of increasing glucose in women.
In terms of site-specific associations with glucose homeostasis, T2DM increases the risk of fracture in cortical-bone-rich appendicular bone. 31 A study in women found that diabetes was associated with unfavourable cortical bone microarchitecture; higher glucose was associated with lower cortical volumetric BMD. 12 In line with these findings, we observed negative association between 2-hour glucose and BMD only at cortical-bone-rich appendicular bone such as the arms. Our findings suggest that cortical and trabecular microarchitectural compartments might respond differently to increasing glucose levels.
We also examined the relationship of lean and fat mass with example by releasing peptides such as irisin.
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Fat mass was positively correlated with BMD, especially at weight-bearing sites such as the pelvis and legs in women, and pelvis in men in univariate analysis, which became insignificant after adjustment for lean mass. Our results are consistent with early studies suggesting fat mass may be beneficial to bone mass as a source of passive mechanical loading. 36 However, recent studies with adjustment for body weight or lean mass suggested that fat might be harmful to bone. 37 Studies using magnetic resonance spectroscopy found bone marrow fat to be an independent negative determinant of BMD. 38 In the current study, we could not discern different fat depots, especially bone marrow fat, and fat may exert endocrine or paracrine effects by releasing adipokines, which needs to be further studied.
Our study has several strengths. We measured glucose homeostasis indices in over 750 patients using euglycaemic-hyperinsulinaemic clamps. In addition, subjects did not have confounding comorbidities affecting skeletal phenotypes, which enabled us to assess properly the relationship of glucose metabolism with bone mineral density. A limitation of our study is that it was cross-sectional and thus could not establish causal relationships between glucose impairment and skeletal health. Also, the findings might not be generalizable to other ethnicities as the subjects were solely Mexican-American.
Unfortunately, our cohort lacks measurements of sex hormones, which might have a critical role in the relationship of glucose homeostasis to bone remodelling. Given the relatively young average age of the cohort, there were too few older women to allow analyses stratifying by menopausal status. Markers of bone turnover and BMD measurements at the total hip or femoral neck were not available.
In conclusion, our findings suggest that insulin might exert its anabolic effect through mechanical stimuli from lean mass. We observed a direct negative effect of 2-hour glucose that was more pronounced at cortical-bone-dominant sites in women, which needs to be further studied. Lastly, we confirm that lean mass is a strong predictor of bone mass, highlighting the clinical importance of sarcopaenia in assessing skeletal health and risk of fracture.
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